Predictive Systems Toxicology.
暂无分享,去创建一个
Hector Zenil | Narsis A Kiani | Jesper Tegner | Ming-Mei Shang | J. Tegnér | H. Zenil | N. Kiani | Ming-Mei Shang
[1] Navdeep Jaitly,et al. A Structure-Based Approach for Mapping Adverse Drug Reactions to the Perturbation of Underlying Biological Pathways , 2010, PloS one.
[2] Tingjun Hou,et al. ADMET evaluation in drug discovery: 15. Accurate prediction of rat oral acute toxicity using relevance vector machine and consensus modeling , 2016, Journal of Cheminformatics.
[3] Roded Sharan,et al. Combining Drug and Gene Similarity Measures for Drug-Target Elucidation , 2011, J. Comput. Biol..
[4] A. Barabasi,et al. Drug—target network , 2007, Nature Biotechnology.
[5] B. Petrovska,et al. Historical review of medicinal plants’ usage , 2012, Pharmacognosy reviews.
[6] V. Chelliah,et al. The promises of quantitative systems pharmacology modelling for drug development , 2016, Computational and structural biotechnology journal.
[7] Paul Flecknell,et al. Replacement, reduction and refinement. , 2002, ALTEX.
[8] Ben Y. Reis,et al. Predicting Adverse Drug Events Using Pharmacological Network Models , 2011, Science Translational Medicine.
[9] Jean-Pierre Lepoittevin,et al. Allergic contact dermatitis caused by naturally occurring quinones , 1991, Pharmaceutisch Weekblad.
[10] Nina Jeliazkova,et al. AMBIT RESTful web services: an implementation of the OpenTox application programming interface , 2011, J. Cheminformatics.
[11] Andrew L. Hopkins,et al. Drug discovery: Predicting promiscuity , 2009, Nature.
[12] R. Sharan,et al. PREDICT: a method for inferring novel drug indications with application to personalized medicine , 2011, Molecular systems biology.
[13] Andreas Bender,et al. ARWAR: A network approach for predicting Adverse Drug Reactions , 2016, Comput. Biol. Medicine.
[14] Hongkang Mei,et al. Systematic Prediction of Pharmacodynamic Drug-Drug Interactions through Protein-Protein-Interaction Network , 2013, PLoS Comput. Biol..
[15] Yuanjia Hu,et al. Network Analysis of Drug–target Interactions: A Study on FDA-approved New Molecular Entities Between 2000 to 2015 , 2017, Scientific Reports.
[16] Günter Klambauer,et al. DeepTox: Toxicity Prediction using Deep Learning , 2016, Front. Environ. Sci..
[17] William J Jusko,et al. Diversity of mechanism-based pharmacodynamic models. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[18] Nina Jeliazkova,et al. Toxmatch--a chemical classification and activity prediction tool based on similarity measures. , 2008, Regulatory toxicology and pharmacology : RTP.
[19] R. M. Muir,et al. Correlation of Biological Activity of Phenoxyacetic Acids with Hammett Substituent Constants and Partition Coefficients , 1962, Nature.
[20] Yeyejide A. Adeleye,et al. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment. , 2015, Toxicology.
[21] Mark T D Cronin,et al. A review of the use of in silico methods to predict the chemistry of molecular initiating events related to drug toxicity , 2011, Expert opinion on drug metabolism & toxicology.
[22] Anna Guryanova,et al. sbv IMPROVER: Modern Approach to Systems Biology. , 2017, Methods in molecular biology.
[23] Hector Zenil,et al. Methods of information theory and algorithmic complexity for network biology. , 2014, Seminars in cell & developmental biology.
[24] Xin Li,et al. Clarifying off-target effects for torcetrapib using network pharmacology and reverse docking approach , 2012, BMC Systems Biology.
[25] Ruth Huey,et al. Computational protein–ligand docking and virtual drug screening with the AutoDock suite , 2016, Nature Protocols.
[26] P. Bork,et al. Systematic identification of proteins that elicit drug side effects , 2013, Molecular systems biology.
[27] F. Azuaje,et al. Drug-target network in myocardial infarction reveals multiple side effects of unrelated drugs , 2011, Scientific reports.
[28] H. Kitano. Systems Biology: A Brief Overview , 2002, Science.
[29] D. K. Arrell,et al. Network Systems Biology for Drug Discovery , 2010, Clinical pharmacology and therapeutics.
[30] George Kurian,et al. Google's Neural Machine Translation System: Bridging the Gap between Human and Machine Translation , 2016, ArXiv.
[31] Sunghoon Kim,et al. Rational drug repositioning guided by an integrated pharmacological network of protein, disease and drug , 2012, BMC Systems Biology.
[32] Lin He,et al. DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical–protein interactome , 2011, Nucleic Acids Res..
[33] Thomas Hartung,et al. Food for thought ... on globalisation of alternative methods. , 2007, ALTEX.
[34] Philip Hunter,et al. A toxic brew we cannot live without , 2008, EMBO reports.
[35] Ruth Nussinov,et al. Structure and dynamics of molecular networks: A novel paradigm of drug discovery. A comprehensive review , 2012, Pharmacology & therapeutics.
[36] K R Przybylak,et al. Hepatotoxicity: A scheme for generating chemical categories for read-across, structural alerts and insights into mechanism(s) of action , 2013, Critical reviews in toxicology.
[37] Pantelis Sopasakis,et al. Collaborative development of predictive toxicology applications , 2010, J. Cheminformatics.
[38] J. Irwin,et al. Lead discovery using molecular docking. , 2002, Current opinion in chemical biology.
[39] C. Dobson. Chemical space and biology , 2004, Nature.
[40] Byunghan Lee,et al. Deep learning in bioinformatics , 2016, Briefings Bioinform..
[41] R. Altman,et al. Integrating systems biology sources illuminates drug action , 2014, Clinical pharmacology and therapeutics.
[42] Thomas Hartung,et al. Lessons Learned from Alternative Methods and their Validation for a New Toxicology in the 21st Century , 2010, Journal of toxicology and environmental health. Part B, Critical reviews.
[43] Hao Ding,et al. Similarity-based machine learning methods for predicting drug-target interactions: a brief review , 2014, Briefings Bioinform..
[44] Vladimir B Bajic,et al. In silico toxicology: computational methods for the prediction of chemical toxicity , 2016, Wiley interdisciplinary reviews. Computational molecular science.
[45] Frank R. Burden,et al. Relevance Vector Machines: Sparse Classification Methods for QSAR , 2015, J. Chem. Inf. Model..
[46] J. Chen,et al. Predicting adverse drug reaction profiles by integrating protein interaction networks with drug structures , 2013, Proteomics.
[47] Ping Zhang,et al. Exploring the associations between drug side-effects and therapeutic indications , 2014, J. Biomed. Informatics.
[48] P. Aloy,et al. Unveiling the role of network and systems biology in drug discovery. , 2010, Trends in pharmacological sciences.
[49] Sebastian Thrun,et al. Dermatologist-level classification of skin cancer with deep neural networks , 2017, Nature.
[50] Jian Wang,et al. In Silico Elucidation of the Molecular Mechanism Defining the Adverse Effect of Selective Estrogen Receptor Modulators , 2007, PLoS Comput. Biol..
[51] Hector Zenil,et al. A perspective on bridging scales and design of models using low-dimensional manifolds and data-driven model inference , 2016, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.
[52] Robert P. Sheridan,et al. Random Forest: A Classification and Regression Tool for Compound Classification and QSAR Modeling , 2003, J. Chem. Inf. Comput. Sci..
[53] Chang Liu,et al. Predicting Drug–Target Interactions Using Probabilistic Matrix Factorization , 2013, J. Chem. Inf. Model..
[54] J. Bailar,et al. Toxicity Testing in the 21st Century: A Vision and a Strategy , 2010, Journal of toxicology and environmental health. Part B, Critical reviews.
[55] Hector Zenil,et al. A Decomposition Method for Global Evaluation of Shannon Entropy and Local Estimations of Algorithmic Complexity , 2016, Entropy.
[56] A. Barabasi,et al. Network-based in silico drug efficacy screening , 2016, Nature Communications.
[57] I. Farkas,et al. Signalogs: Orthology-Based Identification of Novel Signaling Pathway Components in Three Metazoans , 2011, PloS one.
[58] Ruth Nussinov,et al. Principles of docking: An overview of search algorithms and a guide to scoring functions , 2002, Proteins.
[59] Michael J. Keiser,et al. Large Scale Prediction and Testing of Drug Activity on Side-Effect Targets , 2012, Nature.
[60] Meindert Danhof,et al. Systems pharmacology - Towards the modeling of network interactions. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[61] Daniel R. Caffrey,et al. Structure-based maximal affinity model predicts small-molecule druggability , 2007, Nature Biotechnology.
[62] Kriston L. McGary,et al. Systematic discovery of nonobvious human disease models through orthologous phenotypes , 2010, Proceedings of the National Academy of Sciences.
[63] Xiaobo Zhou,et al. Semi-supervised drug-protein interaction prediction from heterogeneous biological spaces , 2010, BMC Systems Biology.
[64] M. Ghert,et al. Lost in translation: animal models and clinical trials in cancer treatment. , 2014, American journal of translational research.
[65] P. Baldi,et al. Searching for exotic particles in high-energy physics with deep learning , 2014, Nature Communications.
[66] Saumitra Das,et al. Interplay between NS3 protease and human La protein regulates translation-replication switch of Hepatitis C virus , 2011, Scientific reports.
[67] Sherry L. Jenkins,et al. Network analysis of FDA approved drugs and their targets. , 2007, The Mount Sinai journal of medicine, New York.
[68] David Vidal,et al. The In Vitro Pharmacological Profile of Drugs as a Proxy Indicator of Potential In Vivo Organ Toxicities. , 2016, Chemical research in toxicology.
[69] Liang Zhao,et al. Mapping the human toxome by systems toxicology. , 2014, Basic & clinical pharmacology & toxicology.
[70] Emilio Benfenati,et al. Comparison and Possible Use of In Silico Tools for Carcinogenicity Within REACH Legislation , 2011, Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews.
[71] S. J. Campbell,et al. Visualizing the drug target landscape. , 2010, Drug discovery today.
[72] Eva Schlede,et al. Development and Prevalidation of a List of Structure–Activity Relationship Rules to be Used in Expert Systems for Prediction of the Skin-sensitising Properties of Chemicals , 2004, Alternatives to laboratory animals : ATLA.
[73] Narsis A Kiani,et al. Systems Toxicology: Systematic Approach to Predict Toxicity. , 2016, Current pharmaceutical design.
[74] Ann M. Richard,et al. DSSTox chemical-index files for exposure-related experiments in ArrayExpress and Gene Expression Omnibus: enabling toxico-chemogenomics data linkages , 2009, Bioinform..
[75] David S. Goodsell,et al. A semiempirical free energy force field with charge‐based desolvation , 2007, J. Comput. Chem..
[76] Gary W Caldwell,et al. ADME optimization and toxicity assessment in early- and late-phase drug discovery. , 2009, Current topics in medicinal chemistry.
[77] Baldomero Oliva,et al. GUILDify: a web server for phenotypic characterization of genes through biological data integration and network-based prioritization algorithms , 2014, Bioinform..
[78] Nick Plant,et al. An introduction to systems toxicology , 2015 .
[79] Yoshihiro Yamanishi,et al. Predicting drug side-effect profiles: a chemical fragment-based approach , 2011, BMC Bioinformatics.
[80] Inna Kuperstein,et al. Network-based approaches for drug response prediction and targeted therapy development in cancer. , 2015, Biochemical and biophysical research communications.
[81] J. Mestres,et al. Drug‐Target Networks , 2010, Molecular informatics.
[82] C. Tannert,et al. High-Throughput Omics Technologies: Potential Tools for the Investigation of Influences of EMF on Biological Systems , 2009, Current genomics.
[83] H. Yabuuchi,et al. Analysis of multiple compound–protein interactions reveals novel bioactive molecules , 2011, Molecular systems biology.
[84] Jie Shen,et al. Comparison of Cramer classification between Toxtree, the OECD QSAR Toolbox and expert judgment. , 2015, Regulatory toxicology and pharmacology : RTP.
[85] Shiwen Zhao,et al. A co-module approach for elucidating drug-disease associations and revealing their molecular basis , 2012, Bioinform..
[86] Tim Chapman. Lab automation and robotics: Automation on the move , 2003, Nature.
[87] Elena Marchiori,et al. Gaussian interaction profile kernels for predicting drug-target interaction , 2011, Bioinform..
[88] M. Schroeder,et al. Drug repositioning through incomplete bi-cliques in an integrated drug-target-disease network. , 2012, Integrative biology : quantitative biosciences from nano to macro.
[89] Mohieddin Jafari,et al. Updates on drug-target network; facilitating polypharmacology and data integration by growth of DrugBank database , 2015, Briefings Bioinform..
[90] Gilles Clermont,et al. Computational disease modeling – fact or fiction? , 2009, BMC Systems Biology.
[91] Laetitia Martin-Chanas,et al. Identify drug repurposing candidates by mining the Protein Data Bank , 2011, Briefings Bioinform..
[92] Darrell R Abernethy,et al. Systems pharmacology to predict drug toxicity: integration across levels of biological organization. , 2013, Annual review of pharmacology and toxicology.
[93] Guigang Zhang,et al. Deep Learning , 2016, Int. J. Semantic Comput..
[94] Lucila Ohno-Machado,et al. Making it personal: translational bioinformatics , 2013, J. Am. Medical Informatics Assoc..
[95] Donald E. Mager,et al. A Mechanism-Based PK/PD Model for Hematological Toxicities Induced by Antibody-Drug Conjugates , 2017, The AAPS Journal.
[96] Jukka-Pekka Onnela,et al. Community Structure in Time-Dependent, Multiscale, and Multiplex Networks , 2009, Science.
[97] A. Butte,et al. Predicting Adverse Drug Reactions Using Publicly Available PubChem BioAssay Data , 2011, Clinical pharmacology and therapeutics.
[98] P. Bork,et al. Network Neighbors of Drug Targets Contribute to Drug Side-Effect Similarity , 2011, PloS one.
[99] Zhi-Pei Liang,et al. High‐resolution 1H‐MRSI of the brain using SPICE: Data acquisition and image reconstruction , 2016, Magnetic resonance in medicine.
[100] Hector Zenil,et al. Evaluating Network Inference Methods in Terms of Their Ability to Preserve the Topology and Complexity of Genetic Networks , 2015, Seminars in cell & developmental biology.
[101] Sanjay Joshua Swamidass,et al. Mining small-molecule screens to repurpose drugs , 2011, Briefings Bioinform..
[102] Yoshihiro Yamanishi,et al. Drug Side-Effect Prediction Based on the Integration of Chemical and Biological Spaces , 2012, J. Chem. Inf. Model..
[103] P. Bork,et al. Drug discovery in the age of systems biology: the rise of computational approaches for data integration. , 2012, Current opinion in biotechnology.
[104] David Vidal,et al. Large-Scale Predictive Drug Safety: From Structural Alerts to Biological Mechanisms. , 2015, Chemical research in toxicology.